Impact of Anticoagulant Class on Long-Term Bioprosthesis Durability Following Transcatheter Aortic Valve Replacement
No significant differences were observed between VKAs and DOACs on valve durability outcomes. Further studies with longer follow-up, larger population, and randomized designs are warranted to confirm these findings.
Authors
- Frederic Beaupré (ORCID: https://orcid.org/0000-0003-0630-3144)
- Éric Dumont (ORCID: https://orcid.org/0000-0001-7513-0326)
- Carlos Giuliani (ORCID: https://orcid.org/0000-0002-3157-4598)
- Juan Portillo (ORCID: https://orcid.org/0000-0002-2756-7635)
- Jean Porterie (ORCID: https://orcid.org/0000-0001-7695-0844)
- Erwan Salaün (ORCID: https://orcid.org/0000-0003-4393-6696)
- Jean‐Michel Paradis (ORCID: https://orcid.org/0000-0002-3428-617X)
- Siamak Mohammadi (ORCID: https://orcid.org/0000-0001-7622-4172)
- Pablo Vidal-Calés (ORCID: https://orcid.org/0000-0002-0815-8609)
- Marisa Avvedimento (ORCID: https://orcid.org/0000-0002-8443-7888)
- Anthony Poulin
- Antonin Trimaille (ORCID: https://orcid.org/0000-0001-9279-4220)
- Josep Rodés-Cabau
Institutions
- Université Laval (CA)
Publication Details
- Journal
- Structural Heart
- Published
- 2025-12-13
- DOI
- https://doi.org/10.1016/j.shj.2025.100786
- Primary Topic
- Cardiac Valve Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00